Circumvent PCV G2 (Canada)

Porcine Circovirus Vaccine, Type 2, Killed Baculovirus Vector

This product has been shown effective for the vaccination of healthy swine 3 days or 3 weeks of age or older against Porcine Circovirus Type 2. Duration of immunity has been shown to be at least 20 weeks. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov. This product has been shown effective against viremia and in the reduction of viral shedding and lymphoid infection caused by Porcine Circovirus Type 2. Composition: This product contains a subunit vaccine based on Porcine Circovirus Type 2a.

ADMINISTRATION and DOSAGE OPTIONS: Allow the vaccine to reach an ambient temperature of 16°-27°C (60°-80°F) and shake well prior to use. Use aseptic technique. OPTION 1: Vaccinate pigs intramuscularly at 3 weeks of age or older with a single 2 mL dose. OPTION 2: Vaccinate pigs intramuscularly as early as 3 days of age with a 1 mL dose followed by a second 1 mL dose 3 weeks later.

CAUTIONS: Store refrigerated at 2°-8°C (35°-46°F). Do not freeze. Shake well before using. Do not mix with other products. This product has not been tested in pregnant animals. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. The vaccine may induce significant localized adverse reactions, particularly following booster vaccination. Localized reactions resolve 1-35 days following vaccination. If allergic reaction occurs, treat with epinephrine. In the event of high maternal antibodies, vaccination at 3 days of age is not recommended. Caution should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

PRESERVATIVES: Gentamicin and thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a, Merck Animal Health, Omaha, Nebraska 68103 USA

VLN 165A / PCN 19K5.R4

1 866 683-7838 (Canada)

CPN: 1208263.2